site stats

Ontx earnings

WebOnconova Therapeutics Inc. analyst estimates, including ONTX earnings per share estimates and analyst recommendations. Web30 de mar. de 2024 · Erweiterte Suche Einloggen

Onconova Therapeutics - ONTX News Today - MarketBeat

WebView today's Onconova Therapeutics Inc stock price and latest ONTX news and analysis. ... Onconova Therapeutics earnings beat by $0.02, revenue fell short of estimates. By Investing.com Web11 de abr. de 2024 · Inogen Price Performance. Shares of INGN opened at $12.78 on Tuesday. The company has a market capitalization of $293.56 million, a price-to-earnings ratio of -3.49 and a beta of 1.03. map of bella vista nsw https://theuniqueboutiqueuk.com

Onconova Therapeutics, Inc. Wirtschaftsprüfer äußert Zweifel an …

Web12 de ago. de 2024 · Onconova Therapeutics, Inc.Which belongs to the Zacks Medical - Drugs industry, posted revenues of $0.06 million for the quarter ended June 2024, … Web17 de mar. de 2024 · ONTX Onconova Therapeutics, Inc.Earnings Date & History. 10.68K followers. $0.80 0.02 ( +1.91%) 3:56 PM 03/17/23. NASDAQ $USD Post-Market: … WebEarnings for Onconova Therapeutics (ONTX) Earnings in 2024 (TTM): -$17.31 M According to Onconova Therapeutics's latest financial reports the company's current earnings (TTM) are -$17.31 M.In 2024 the company made an earning of -$16.17 M an increase over its 2024 earnings that were of -$25.16 M.The earnings displayed on this … map of bella coola bc

ONTX Stock Price and Chart — NASDAQ:ONTX — TradingView

Category:ONTX Stock Price and Chart — NASDAQ:ONTX — TradingView

Tags:Ontx earnings

Ontx earnings

ONTX - Onconova Therapeutics Inc Stock quote - CNNMoney.com …

WebOnconova Therapeutics, Inc. (ONTX) CEO Steve Fruchtman on Q2 2024 Results - Earnings Call Transcript Seeking Alpha - Aug 11, 2024, 11:14PM Onconova Therapeutics appoints company's CFO Mark Guerin ... WebOnconova Therapeutic (ONTX) reports earnings on 3/16/2024. Shares are down 10.1% since reporting last quarter. The Earnings Whisper Score gives the statistical odds for …

Ontx earnings

Did you know?

WebOnconova Therapeutics, Inc. (NASDAQ:ONTX) Q4 2024 Earnings Call Transcript March 16, 2024 Operator: Ladies and gentlemen, thank you for standing by. Welcome to the … WebUpcoming Earnings - US Historical Earnings - World. United States Canada UK Hong Kong Japan Australia New Zealand. ... ONTX available to be shorted at a leading prime brokerage. It is not the total number of shares available to short, nor is it the short interest.

WebOnconova Therapeutics (ONTX) will release its next earnings report on May 16, 2024. In the last quarter Onconova Therapeutics reported -$0.278 EPS in relation to -$0.26 … WebFind real-time ONTX - Onconova Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. ... Earnings growth (this year)-45.33%: Earnings growth (next 5 years)--

WebOnconova Therapeutics, Inc. (NASDAQ:ONTX) Q4 2024 Earnings Call Transcript March 16, 2024 Operator: Ladies and gentlemen, thank you for standing by. WebFind the latest Earnings Report Date for Onconova Therapeutics, Inc. Common Stock (ONTX) at Nasdaq.com. Onconova Therapeutics, Inc. Common Stock (ONTX) Earnings Report Date Nasdaq Skip to main ...

WebOnconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing products for patients with cancer. The Company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova’s novel, proprietary multi-kinase ...

Web16 de mar. de 2024 · Onconova Therapeutics (ONTX) Earnings Dates & Reports. Earnings Insights. Latest Release. Mar 16, 2024. EPS / Forecast. -0.26 / -0.2775. Revenue / … kristin beamon chiropractorWebONTX Complete Onconova Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. map of bellagio lake comoWeb4 de jun. de 2024 · Onconova Therapeutics, Inc. (ONTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. kristin begley capital rx